by this means component separation was rapid and plasma-exchange efficient , which offers a promising way for symptomatic treatment when a qualitative or quantitative modification of the composition of the blood is wanted ( e.g . diminuation of hyperviscosity , modifications of circulating immune complexes , elimination of toxic antibodies and protein bound toxins ) .
C0003313
circulating immune complexes
C0003241
antibodies